WCM
GSK icon

Westend Capital Management’s GSK GSK Stock Holding History

Westend Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.97K Sell
72
-3
-4% -$163 ﹤0.01% 195
2025
Q4 		$3.68K Hold
75
– – ﹤0.01% 201
2025
Q3 		$3.24K Buy
+75
New +$2.93K ﹤0.01% 217

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Westend Capital Management's GSK Position: Q1 2026 in Review

Westend Capital Management reduced its GSK (GSK) stake by 4% in Q1 2026, selling an estimated $163 and leaving 72 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #195.

Westend Capital Management first reported a position in GSK in Q3 2025 and has held it in 3 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Westend Capital Management held 72 shares of GSK worth $3.97K as of Q1 2026.
  • Westend Capital Management sold 3 GSK shares in Q1 2026, an estimated $163.
  • GSK made up ﹤0.01% of Westend Capital Management's portfolio in Q1 2026, its #195 holding.
  • Westend Capital Management first reported a position in GSK in Q3 2025 and has held it in 3 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Westend Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.